This year's game had an extra layer of emotion that brought the Panthers together. Assistant coach Hoa Nguyen is in a current ...

The company recently secured approval for olezarsen in FCS, and looks odds on for a follow-up approval in SHTG. Click here to ...

Dr. Audrey Gabelle is a Professor of Neurology, MD, PhD, Neurologist and Doctor in Neurosciences at the Memory Resources Research Center, the Rare and Early Dementia Reference Center and the European ...

Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments ...

Charity walker Tracey Howe is approaching a half-way milestone on her 5000-mile round Britain hike. The 61-year-old has also ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

Science reveals sleep needs vary dramatically between individuals. Discover your personal sleep requirement, why it matters, ...

As previously reported, Wolfe Research analyst Andy Chen upgraded Intellia Therapeutics (NTLA) to Outperform from Peer Perform with a $21 price ...

Despite a lot of advancements in our understanding of dementia over the past few decades, doctors still don’t have a reliable ...

New study links norepinephrine to reduced brain inflammation in Alzheimer’s, offering a potential early treatment target.

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...

New research identifies 17 modifiable factors that can reduce your risk of stroke, dementia, and depression simultaneously, ...